ADMA Biologics, Inc. (ADMA)
11.01
-0.22
(-1.96%)
USD |
NASDAQ |
Oct 21, 16:00
10.96
-0.05
(-0.45%)
After-Hours: 20:00
ADMA Biologics Net Income (Annual) : 146.93M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 146.93M |
| December 31, 2024 | 197.67M |
| December 31, 2023 | -28.24M |
| December 31, 2022 | -65.90M |
| December 31, 2021 | -71.65M |
| December 31, 2020 | -75.75M |
| December 31, 2019 | -48.28M |
| December 31, 2018 | -65.74M |
| Date | Value |
|---|---|
| December 31, 2017 | -43.76M |
| December 31, 2016 | -19.52M |
| December 31, 2015 | -17.97M |
| December 31, 2014 | -16.81M |
| December 31, 2013 | -15.53M |
| December 31, 2012 | -7.301M |
| December 31, 2011 | -5.904M |
| December 31, 2010 | -5.948M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Vericel Corp. | 16.52M |
| BioMarin Pharmaceutical, Inc. | 348.90M |
| Emergent BioSolutions, Inc. | 52.60M |
| Exelixis, Inc. | 782.57M |
| Akebia Therapeutics, Inc. | -5.345M |